Retraction
Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study
Paper Information
Record ID:
20361
Journal:
Publication Date:
September 27, 2018
Retraction Date:
April 25, 2019
(6.6 years years ago)
Subjects:
Institutions:
Country:
🇰🇷 South KoreaArticle Type:
Publisher:
American Medical Association
Open Access:
No
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (239)
239
Total Citations220
Post-Retraction(92.1%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
39
Within 1 year
132
After 2+ years
2153
Days since retraction (latest)
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Apr 2020
351 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Apr 2020
342 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Mar 2020
340 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Mar 2020
330 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Mar 2020
325 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Feb 2020
291 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Feb 2020
288 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Feb 2020
282 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jan 2020
274 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jan 2020
274 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jan 2020
258 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jan 2020
252 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jan 2020
251 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jan 2020
251 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jan 2020
251 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jan 2020
251 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jan 2020
251 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Dec 2019
249 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Dec 2019
245 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Dec 2019
245 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Dec 2019
235 days after retraction
TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFβ1/Smad3, and NF-κB/NLRP3 inflammasome signaling pathways
Jing Zhao, Ming Han, Li Zhou et al. (12 authors)
Hepatology International
Published: Nov 2019
26 citations
26 citations
211 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Oct 2019
189 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Oct 2019
188 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Oct 2019
169 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Oct 2019
159 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Oct 2019
159 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Sep 2019
144 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Sep 2019
135 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Sep 2019
129 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jul 2019
96 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jun 2019
64 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jun 2019
37 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jun 2019
37 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jun 2019
37 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jun 2019
37 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Jun 2019
37 days after retraction
The HBx–CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1
Yajun Li, Yongming Fu, Xingwang Hu et al. (8 authors)
Cell Death and Disease
Open Access
Published: May 2019
41 citations
41 citations
33 days after retraction
Paper citing Risk of hepatocellular carcinoma in patients treat...
Unknown Authors
Unknown Journal
Published: Apr 2019
14 days before retraction
Quick Stats
Total Citations:
239
Years Since Retraction:
6.6 years
Open Access:
No
Last Checked:
Never